These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30258293)

  • 41. Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices.
    Kortekaas KA; den Exter PL; Beeres SLMA; Palmen M; Jukema JW; Huisman MV; Tops LF
    Front Cardiovasc Med; 2022; 9():969766. PubMed ID: 36312273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombus on the inflow cannula of the HeartWare HVAD: an update.
    Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF
    Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflow Cannula Position Influences Improvement in Mitral Regurgitation After Ventricular Assist Device Implantation.
    Pasrija C; Sawan MA; Sorensen E; Gammie JS; Madathil R; Tran D; Wang L; Ton VK; Feller E; Griffith BP; Kon ZN; Kaczorowski DJ
    ASAIO J; 2021 Apr; 67(4):423-429. PubMed ID: 33769997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrical storm in the early phase of HeartMate
    Corre J; Picard F; Garcia R; Zemmoura A; Derval N; Denis A; Romen A; Nubret K; Jais P; Haissaguerre M; Dos Santos P; Barandon L; Sacher F
    Arch Cardiovasc Dis; 2018 May; 111(5):332-339. PubMed ID: 29217463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation.
    Kato TS; Colombo PC; Nahumi N; Kitada S; Takayama H; Naka Y; Di Tullio MR; Homma S; Mancini D; Jorde UP; Uriel N
    Echocardiography; 2014; 31(1):E5-9. PubMed ID: 24063315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate 3™.
    Hanke JS; Mariani S; Merzah AS; Bounader K; Li T; Haverich A; Schmitto JD; Dogan G
    J Cardiovasc Surg (Torino); 2021 Dec; 62(6):646-651. PubMed ID: 34057162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Ventricular Arrhythmia Ablation in Patients With Heart Mate II Left Ventricular Assist Devices: An Evaluation of Ablation Therapy.
    Snipelisky D; Reddy YN; Manocha K; Patel A; Dunlay SM; Friedman PA; Munger TM; Asirvatham SJ; Packer DL; Cha YM; Kapa S; Brady PA; Noseworthy PA; Maleszewski JJ; Mulpuru SK
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):68-77. PubMed ID: 27766717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II.
    Akin S; Soliman OI; Constantinescu AA; Akca F; Birim O; van Domburg RT; Manintveld O; Caliskan K
    Neth Heart J; 2016 Feb; 24(2):134-42. PubMed ID: 26689927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device.
    Imamura T; Adatya S; Chung B; Nguyen A; Rodgers D; Sayer G; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Medvedofsky D; Jeevanandam V; Lang R; Estep JD; Burkhoff D; Uriel N
    J Card Fail; 2018 Mar; 24(3):159-166. PubMed ID: 28982636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HeartMate 3 left ventricular assist device implant after excision of a large apical aneurysm.
    Chamogeorgakis T; Kostopanagiotou K; Behler A; Apostolou D
    Proc (Bayl Univ Med Cent); 2020 Jul; 33(3):455-456. PubMed ID: 32675986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Principles of HeartMate II implantation to avoid pump malposition and migration.
    Adamson RM; Mangi AA; Kormos RL; Farrar DJ; Dembitsky WP
    J Card Surg; 2015 Mar; 30(3):296-9. PubMed ID: 25472467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Stepwise Approach to Left Ventricular Assist Device Pump Thrombosis.
    Kocabeyoglu SS; Kervan U; Sert DE; Karahan M; Unal EU; Catav Z; Pac M
    Heart Lung Circ; 2021 Apr; 30(4):567-576. PubMed ID: 32843296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing left ventricular assist device inflow cannula angle between median sternotomy and thoracotomy using 3D reconstructions.
    Pearman M; Emmanuel S; Jansz P; Watson A; Connellan M; Iyer A; Barua S; Hayward CS
    Artif Organs; 2023 Jun; 47(6):1018-1028. PubMed ID: 36582131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful removal of a potentially lethal left atrial thrombus detected by transesophageal echocardiography following the removal of a left ventricular assist device inflow cannula.
    Chuang CC; Lee CC; Liao SW; Ting CK; Chu CC; Chan KH; Lin SM
    J Chin Med Assoc; 2012 Oct; 75(10):543-6. PubMed ID: 23089409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation.
    Salna M; Garan AR; Kirtane AJ; Karmpaliotis D; Green P; Takayama H; Sanchez J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):499-506. PubMed ID: 31986207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.